(Q74713944)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209356%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Combination treatment of bullous pemphigoid with anti-CD20 and anti-CD25 antibodies in a patient with chronic graft-versus-host disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209356%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

Szabolcs P

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209356%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Reese M

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209356%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Yancey KB

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209356%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Hall RP

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209356%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Kurtzberg J

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209356%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 September 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209356%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

12 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209356%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209356%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209356%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

327-329

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209356%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703654

12 November 2019

exact match

0 references

cites work

Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703654

7 January 2021

Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703654

7 January 2021

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703654

7 January 2021

Treatment of refractory autoimmune haemolytic anaemia with anti-CD20 (rituximab)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703654

7 January 2021

Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703654

7 January 2021

The use of antibodies against the IL-2 receptor in transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703654

7 January 2021